NCT02253446View on ClinicalTrials.gov

A Comparison of Analgesic İmpacts of Piroxicam and Diclofenac Sodium in the Treatment of Primary Dysmenorrhea

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Primary Dysmenorrhea
Interventions
DRUG

Piroxicam

20 mg of piroxicam (Feldene ampoule-Pfizer-France) intramuscularly (IM) was given 200 patients,

DRUG

Diclofenac Sodium

Second Group: Diclofenac sodium 75mg (Miyadren ampoule-bulb-Yavuz Istanbul) intramuscularly (IM) was given 200 patients.

Trial Locations (1)

20000

Pamukkale Universty, Denizli

All Listed Sponsors
lead

Pamukkale University

OTHER

NCT02253446 - A Comparison of Analgesic İmpacts of Piroxicam and Diclofenac Sodium in the Treatment of Primary Dysmenorrhea | Biotech Hunter | Biotech Hunter